Veeva Recognized for Industry Leadership by Forbes Magazine and IDC, Among Other Industry Accolades
ZDNet and Nucleus Research also name Veeva a leader for continued innovation in Veeva CRM BARCELONA, Spain–(BUSINESS WIRE)–Veeva Systems (NYSE:…
Pharmaceuticals, Biotechnology and Life Sciences
ZDNet and Nucleus Research also name Veeva a leader for continued innovation in Veeva CRM BARCELONA, Spain–(BUSINESS WIRE)–Veeva Systems (NYSE:…
ZDNet and Nucleus Research also name Veeva a leader for continued innovation in Veeva CRM PLEASANTON, Calif.–(BUSINESS WIRE)–#CRM—Veeva Systems (NYSE:…
BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that it…
DUBLIN–(BUSINESS WIRE)–The “Clinical Trials Market Analysis by Phase (Phase I/II/III/IV), by Study Design (Interventional, Observational, Expanded Access), by Indication (Autoimmune,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that members…
Conference Call Scheduled Today at 8:30 a.m. EDT LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #CNCE—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc, a biotechnology company pioneering a new class of therapeutics based on its proprietary…
Dermatology.com Supports Lower, Predictable Pricing for Many of Bausch Health’s Prescription Dermatology Products at Walgreens 9,500 Retail Pharmacies DEERFIELD, Ill.,…
Revenues of $45.2 billion for the Third Quarter, a 4.9 Percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $1.43…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global sickle cell disease treatment market is expected to grow by USD 1.85 billion during the period 2019-2023,…